Bone Therapeutics Raises Funds for ALLOB Bone Regeneration Product

Bone Therapeutics raised €3.3 million (~USD $3.7 million) through an equity private placement. Gross proceeds will be used to advance Bone Therapeutics’ lead orthopedic asset, ALLOB, through mid-stage clinical development, as well as product development outside of orthopedics.

In addition, Bone Therapeutics expects to complete the final...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us